REVIEW
Add like
Add dislike
Add to saved papers

Recurrence of cerebral arteriovenous malformations in children: report of two cases and review of the literature.

Surgical Neurology 2004 October
BACKGROUND: Angiography is considered the standard to assess the treatment success of cerebral arteriovenous malformations (AVMs). When postoperative angiograms show neither residual nidus nor early draining veins, patients are considered cured, and the risks of hemorrhage are eliminated. However, this notion is challenged by the development of recurrent AVMs in children. In our report, 2 children developed recurrent AVMs after undergoing complete resection, which was documented by postoperative angiography. We review other similar cases reported in the literature to help establish guidelines for postoperative monitoring.

METHODS: In this retrospective review, 36 children underwent complete surgical resection of cerebral AVMs that were documented by intra- or postoperative angiography. After a follow-up period ranging from 1 to 17 years, rates of recurrence were assessed.

RESULTS: Although angiographic documentation showed complete resection, 2 children developed recurrences 3 and 5 years later. Among these 36 children, the recurrence rate was 5.5% at follow-up (mean 9 years).

CONCLUSIONS: Based on our data and review of the literature, intra- or early postoperative angiography is essential to exclude the presence of a residual nidus but does not ensure cure of the AVMs in children. If postoperative angiographic scans are obtained too early, postoperative changes may prevent the detection of a residual nidus. Therefore, we recommend that angiographic scans be obtained intraoperatively or early postoperatively to document complete resection and again at 1 and 5 years after surgical resection.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app